Anzeige
Mehr »
Samstag, 21.02.2026 - Börsentäglich über 12.000 News
Breaking News: TeaRx erobert Großbritannien im Sturm?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
09:50Samstag-Meldung zu BIONTECH SE ADR: Jetzt könnte es explodieren!3
07:5871% Potenzial! Warum Tempus AI Anleger reizt9
03:48Vanda surges as FDA approves Bysanti for bipolar disorder, schizophrenia5
00:06FDA approves Vanda's Bysanti for bipolar disorder, schizophrenia4
FrVanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Announces FDA Approval of BYSANTI (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation161WASHINGTON, Feb. 20, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved...
► Artikel lesen
FrBioMarin Pharmaceutical Q4 2025 Earnings Preview2
FrSummit Therapeutics Q4 2025 Earnings Preview2
FrVir Biotechnology Q4 2025 Earnings Preview1
FrStrong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential1
FrIovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)8
FrThe Analyst Verdict: Amgen In The Eyes Of 18 Experts3
FrExpert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts1
Fr5 Analysts Assess GRAIL: What You Need To Know3
FrFDA to review Savara resubmitted Molbreevi BLA1
FrFDA nimmt Zulassungsantrag von Savara für Medikament gegen seltene Lungenkrankheit an2
FrFDA accepts Savara's drug application for rare lung disease2
FrUltragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)2
FrGrail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip?8
FrManuela Buxo To Become Head of Sanofi's (SNY) Specialty Care Global Business Unit3
FrZenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)1
Weiter >>